← Back to Search

Behavioral Intervention

trauma Informed Guilt Reduction Therapy for Post-Traumatic Stress Disorder (PORT Trial)

N/A
Waitlist Available
Led By Shannon Kehle-Forbes, PhD
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8-, 16-, and 28 weeks after the first therapy session
Awards & highlights

PORT Trial Summary

This trial aims to compare the effectiveness of Trauma-Informed Guilt Reduction (TrIGR) Therapy and Prolonged Exposure Therapy in veterans with PTSD and trauma-related guilt. It wants to

Who is the study for?
This trial is for veterans with PTSD who feel guilt or shame related to their trauma. Participants must be diagnosed with PTSD and have experienced a traumatic event that causes them feelings of guilt.Check my eligibility
What is being tested?
The study compares Trauma-Informed Guilt Reduction (TrIGR) Therapy with Prolonged Exposure (PE) Therapy to see which is better at reducing PTSD symptoms, improving overall functioning, and lessening feelings of guilt and shame.See study design
What are the potential side effects?
While the therapies being tested are not drugs, they may cause emotional discomfort due to recalling traumatic events. Some participants might experience increased anxiety or sadness during treatment.

PORT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8-, 16-, and 28 weeks after the first therapy session
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 8-, 16-, and 28 weeks after the first therapy session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Secondary outcome measures
Brief Psychosocial Functioning Inventory (B-IPF)
Patient Health Questionnaire-9 (PHQ-9)
Trauma Related Guilt Inventory Cognitions Scale (TRGI)
+1 more

PORT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: trauma Informed Guilt Reduction TherapyExperimental Treatment1 Intervention
6 session behavioral intervention focused on trauma-related guilt, shame, and moral injury
Group II: Prolonged Exposure TherapyActive Control1 Intervention
12 session behavioral intervention focused on PTSD symptoms

Find a Location

Who is running the clinical trial?

Veterans Medical Research FoundationLead Sponsor
43 Previous Clinical Trials
4,776 Total Patients Enrolled
University of MinnesotaOTHER
1,379 Previous Clinical Trials
1,588,334 Total Patients Enrolled
Center for Veterans Research and EducationOTHER
11 Previous Clinical Trials
1,332 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being enrolled in this clinical trial?

"As reported on clinicaltrials.gov, the current status of this investigation does not involve patient recruitment. The trial was first registered on June 1st, 2024 and recently updated on February 28th, 2024. Although enrollment is closed for this particular study at present, there are numerous other trials actively seeking participants - a total of 335 to be precise."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure
2024. "Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06296589.
All > Post Traumatic Stress Disorder > Ptsd
~105 spots leftby Jul 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top